Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Oncolytic measles virus strains in the treatment of gliomas Allen C; Paraskevakou G; Liu C; Iankov ID; Msaouel P; Zollman P; Myers R; Peng KW; Russell SJ; Galanis EExpert Opin Biol Ther 2008[Feb]; 8 (2): 213-20BACKGROUND: Recurrent gliomas have a dismal outcome despite use of multimodality treatment including surgery, radiation therapy and chemotherapy. OBJECTIVE: In this article the authors discuss potential applications of oncolytic measles virus strains as novel antitumor agents in the treatment of gliomas. METHODS: Important aspects of measles virus development as an anticancer therapeutic agent including engineering, retargeting and combination studies with other therapeutic modalities are discussed. The translational process that led to the first clinical trial of an engineered measles virus derivative in patients with recurrent glioblastoma multiforme is also described. RESULTS/CONCLUSIONS: Oncolytic measles virus strains hold promise as novel antitumor agents in the treatment of gliomas.|*Oncolytic Virotherapy[MESH]|Animals[MESH]|Brain Neoplasms/genetics/immunology/*therapy[MESH]|Glioma/genetics/immunology/*therapy[MESH]|Humans[MESH]|Measles Vaccine/genetics/immunology/*therapeutic use[MESH]|Measles virus/genetics/*immunology[MESH]|Oncolytic Viruses/genetics/*immunology[MESH] |